100 TECHNOLOGY SQUARE, CAMBRIDGE, MA
Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients
Announces First Quarter 2026 Financial Results and Recent Business Highlights
Annual Report to Security Holders
Appoints Jessica Chutter to Board of Directors
Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Investor Presentation
Announces Third Quarter 2025 Financial Results and Recent Business Highlights
Q1
FY 2024
Q3
Q2
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Initial Statement of Beneficial Ownership
S-8 POS
Correspondence
Submission Upload
Post-Effective Amendment to Registration Statement